# Bell Abell Bio Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bell-abell-bio-co

- Industry: Materials
- Headquarters: Gimhae, South Korea
- Latest round: Seed (Apr 28, 2023)
- Investors on record: 1

## About

Founded in 2021 and based in Gimhae, South Korea, Bell Abell Bio Co., Ltd. operates as a manufacturer of natural biomaterials and provides industrialization solutions. As of 2023, Byung-Chan Chung serves as the CEO of the company. In April 2023, Bel Abel Bio raised seed funding from Series Ventures.

The company develops functional biomaterials and offers industrialization solutions based on functional substance efficacy verification using its own efficacy screening system of domestic natural raw materials. The firm also provides smart farm cultivation services.

The organization plans to use the April 2023 funding to strengthen domestic and overseas certification work and R&D, including patent application and registration through the efficacy testing of natural functional materials, and expand sales and marketing capabilities.

## Funding rounds

- Seed, Apr 28, 2023 — Series Ventures

## Investors

- Series Ventures (https://capitalatlas.ai/funds/series-ventures) — Seed